Diagnosis and management of diabetic neuropathy.

被引:32
作者
Perkins B.A. [1 ]
Bril V. [1 ]
机构
[1] Toronto General Hospital, University Health Network, 200 Elizabeth Street, Toronto
关键词
Glycemic Control; Carpal Tunnel Syndrome; Diabetic Neuropathy; Nerve Conduction Study; Plantar Pressure;
D O I
10.1007/s11892-002-0119-x
中图分类号
学科分类号
摘要
Diabetic sensorimotor polyneuropathy (DSP) remains the most common microvascular complication of both type I and type 2 diabetes, and poses a unique set of management challenges in the prevention of foot complications. Although different quantitative tests are available, the preliminary diagnosis of DSP can be reliably made using simple and rapid screening tests in the family physician's office or in the diabetes clinic. The Semmes-Weinstein 10-g monofilament examination is a popular, simple clinical modality for the prediction of early DSP, foot ulceration, and amputation, and, in turn, a predictor of mortality in patients with diabetes. The management of DSP is centered on optimal glycemic control, diligent foot care, and pain control as a means of preventing the progression of DSP and reducing the morbidity associated with foot complications.
引用
收藏
页码:495 / 500
页数:5
相关论文
共 174 条
[1]  
Britland ST(1990)Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration Diabetes 39 898-908
[2]  
Young RJ(1990)Pathways to diabetic limb amputation. Basis for prevention Diabetes Care 13 513-521
[3]  
Sharma AK(1992)Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria Diabetes Care 15 1386-1389
[4]  
Clarke BF(1994)End-stage complications of diabetic neuropathy: foot ulceration Can J Neurol Sci 21 S18-S22
[5]  
Pecoraro RE(2000)Complications of diabetes: screening for retinopathy and management of foot ulcers Qual Health Care 9 137-141
[6]  
Reiber GE(1999)Patient-level estimates of the cost of complications in diabetes in a managed care population Pharmacoeconomics 16 285-295
[7]  
Burgess EM(1999)The progressive cost of complications in type 2 diabetes mellitus Arch Intern Med 159 1873-1880
[8]  
Rith-Najarian SJ(2000)The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system Diabetes Technol Ther 2 S7-S12
[9]  
Stolusky T(1985)Hospital admissions of diabetic patients: information from hospital activity analysis Diabet Med 2 27-32
[10]  
Gohdes DM(1998)The burden of diabetic foot ulcers Am J Surg 176 5S-10S